Paper Details

  1. Home
  2. Paper Details

A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study.

Author: BiermanWfw, BravenboerB, GisolfEh, GroeneveldPhp, HoepelmanA I M, KoopmansP P, LangebeekN, LegrandJ C, MulderP G H, RichterC, SprengerH G, Ten KateR W, Ten NapelC H H, VriesendorpR, van der WerfTs

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Switching to abacavir/lamivudine/zidovudine (ABC/3TC/ZDV) after successful induction with standard antiretroviral therapy (ART) had similar antiviral efficacy compared to continuing a PI-based regimen at 96 weeks after baseline, with improved serum lipids.
Paper Details　
Original Abstract of the Article :
OBJECTIVES: The aim of the study was to test the antiviral efficacy of a triple nucleoside reverse transcriptase inhibitor (NRTI) regimen, with potential beneficial metabolic effects, as maintenance therapy after induction with dual NRTIs and a boosted protease inhibitor (PI). METHODS: An open-labe...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/hiv.12186

データ提供：米国国立医学図書館（NLM）

Triple Nucleoside Therapy for HIV: Finding Stability in the Shifting Sands

HIV treatment is a constant struggle against a constantly evolving enemy. This study investigates the efficacy of a triple nucleoside reverse transcriptase inhibitor (NRTI) regimen as maintenance therapy after initial treatment with a combination of dual NRTIs and a boosted protease inhibitor (PI). The researchers found that switching to a single-class NRTI regimen after successful induction therapy resulted in similar antiviral efficacy compared to continuing the PI-based regimen, with the added benefit of improved serum lipids. This finding is like discovering a stable oasis in the shifting sands of HIV treatment, offering a potentially safer and more effective long-term strategy.

The Oasis of Triple Nucleoside Therapy: A Stable Long-Term Solution for HIV?

The results of this study suggest that a triple NRTI regimen may offer a viable and potentially beneficial long-term maintenance therapy for HIV-infected patients. This finding is like discovering a hidden spring in the desert – offering a refreshing and sustainable source of hope for those living with HIV.

Navigating the Desert of HIV Treatment: Seeking Effective and Sustainable Solutions

This research underscores the need for ongoing research and development of new treatment strategies for HIV. It highlights the importance of finding therapies that are not only effective but also sustainable and well-tolerated over the long term. This is like navigating a vast desert, where the search for a sustainable oasis is crucial for survival and well-being.

Dr. Camel's Conclusion

The discovery of a potentially effective and well-tolerated single-class NRTI regimen for HIV maintenance therapy offers a glimmer of hope in the vast desert of HIV treatment. This research provides a new avenue for exploration and may lead to more effective and sustainable solutions for those living with HIV.

Date :
  1. Date Completed 2015-08-25
  2. Date Revised 2015-01-19
Further Info :

Pubmed ID

25472825

DOI: Digital Object Identifier

10.1111/hiv.12186

Related Literature

Article Analysis
・Effects of lamivudine and zidovudine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.